Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks

Digestion

Volumn 75, Issue 2-3, 2007, Pages 156-163

  Andriulli, Angelo ^a   Forlano, Rosario ^a   Napolitano, Grazia ^a   Conoscitore, Pasquale ^a   Caruso, Nazario ^a   Pilotto, Alberto ^a   Di Sebastiano, Pier Luigi ^a   Leandro, Gioacchino ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Endoscopic retrograde cholangiopancreatography; Pancreatic stents; Pancreatitis, acute; Prophylaxis

Indexed keywords

ARTICLE; BALLOON DILATATION; BLEEDING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CYSTADENOMA; DATA ANALYSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INFECTION; META ANALYSIS; PANCREAS DUCT; PANCREAS INJURY; PANCREATITIS; PERFORATION; PRIORITY JOURNAL; RISK REDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STENT; SYSTEMATIC REVIEW; VATER PAPILLA STENOSIS;

ACUTE DISEASE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; STENTS;

EID: 34548358718     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106774     Document Type: Article

References (30)

1. Andriulli A, Loperfido L, Napoletano G, Niro G, Valvano R, Spirito F, Pilotto A, Forlano R: Incidence rates of post-ERCP complications. A systematic survey of prospective studies. Am J Gastroenterol 2007, in press.
2. Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, De Maio G: Antisecretory versus antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 2003;4:41-48.
3. Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V: Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP. An updated meta-analysis. Gastrointest Endosc 2007;65:624-632.
4. Freeman ML: Role of pancreatic stents in prevention of post-ERCP pancreatitis. JOP 2004;5:322-327.
5. Tarnasky PR: Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indication. J Pancreas 2003;4:58-67.
6. Singh P, Das A, Isenberg G, Wong RCK, Sivak MV, Agrawal D, Chak A: Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004;60:544-550.
7. Brackbill S, Young S, Schoenfeld P, Elta G: A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 2006;64:45-51.
8. Aizawa T, Ueno N: Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001;54:209-213.
9. Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE: Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003;57:291-294.
10. Sherman S, Earle D, Bucksot L, Esber E, Pezzi J, Gottlieb K, Lehman G: Does leaving a main pancreatic stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? Randomized prospective study. Am J Gastroenterol 1995;90:1614A.
11. Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, Hawes R, Lehman G: Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993;39:652-657.
12. Tarnasky P, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH: Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-1524.
13. Harewood GC, Pochron NL, Gostout CJ: Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005;62:367-370.
14. Cremer M, Devière J, Delhaye M, Baize M, Vandermeeren A: Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy 1991;23:171-176.
15. Rossos PG, Kortan P, Haber GB: Complications associated with pancreatic duct stenting. Gastrointest Endosc 1992;38:252.
16. Smits M, Badiga M, Rauws EAJ, Tytgat GNJ, Huibregtse K: Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc 1994;42:461-467.
17. Ashby K, Lo SK: The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum. Gastrointest Endosc 1995;42:306-311.
18. Esber E, Sherman S, Earle D, Pezzi J, Gottlieb K, Lehman G: Complications of minor papilla endoscopic pancreatic sphincterotomy. A review of 236 patients. Gastrointest Endosc 1996;43:405.
19. Soltani S, Lo SK: How safe is endoscopic pancreatic sphincterotomy? Gastrointest Endosc 1996;43:413.
20. Elton E, Howell DA, Parsons WG, Quaseem T, Hanson BL: Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998;47:240-249.
21. Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA: Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002;34:280-285.
22. Norton ID, Gostout CJ, Baron TH, Geller A, Petersen BT, Wiersema MJ: Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 2002;56:239-243.
23. Catalano MF, Linder JD, Chak A, Sivak MV, Raijman I, Geenen JE, Howell DA: Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004;59:225-232.
24. Rashdan A, Fogel EL, McHenry L, Sherman S, Temkit M, Lehman GA: Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004;2:322-329.
25. Ito K, Fujita N, Noda Y, Kobayashi G, Horaguchi J, Takasawa O: Efficacy and safety of prophylactic pancreatic duct stent (Pit-stent) placement in patients at high-risk of post-ERCP pancreatitis. Gut 2005;54(suppl VII):A149.
26. Jadad AR, Moore RA, Carroll D, Jenkins C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
27. Hasselblad V, McCrory DC: Meta-analytic tools for medical decision making: a practical guide. Med Decis Making 1995;15:81-96.
28. Klein S, Simes J, Blackburn GL: Total parenteral nutrition and cancer clinical trial. Cancer 1986;58:1378-1386.
29. Leandro G: Meta-Analysis in Medical Research. Oxford, Blackwell, 2004.
30. Shakoor T, Hogan WJ, Geenen JE: Efficacy of nasopancreatic catheter in the prevention of post ERCP pancreatitis: a prospective randomized controlled trial. Gastrointest Endosc 1992;38:251.